SRR598009
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- KRAS_SIGNALING_DN+0.253
- MYOGENESIS+0.118
- SPERMATOGENESIS+0.102
- HEME_METABOLISM-0.024
- PI3K_AKT_MTOR_SIGNALING-0.046
- APICAL_JUNCTION-0.066
- DNA_REPAIR-0.087
- MITOTIC_SPINDLE-0.094
- G2M_CHECKPOINT-0.122
- WNT_BETA_CATENIN_SIGNALING-0.140
Top 10 suppressed
- TGF_BETA_SIGNALING-0.443
- TNFA_SIGNALING_VIA_NFKB-0.424
- INTERFERON_ALPHA_RESPONSE-0.418
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.394
- OXIDATIVE_PHOSPHORYLATION-0.388
- ANGIOGENESIS-0.378
- MTORC1_SIGNALING-0.378
- APOPTOSIS-0.376
- CHOLESTEROL_HOMEOSTASIS-0.368
- INTERFERON_GAMMA_RESPONSE-0.359
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR613270 | GTEX | — | 0.973 |
| 2 | SRR1467813 | GTEX | — | 0.969 |
| 3 | SRR627299 | GTEX | — | 0.969 |
| 4 | SRR1479802 | GTEX | — | 0.966 |
| 5 | SRR1455060 | GTEX | — | 0.964 |
| 6 | SRR615249 | GTEX | — | 0.964 |
| 7 | SRR1436444 | GTEX | — | 0.960 |
| 8 | SRR627453 | GTEX | — | 0.958 |
| 9 | SRR1328960 | GTEX | — | 0.957 |
| 10 | SRR1388504 | GTEX | — | 0.957 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 3 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| KRAS_SIGNALING_DN | 0.253 | Remibrutinib | — uncovered |
| MYOGENESIS | 0.118 | Inavolisib | — uncovered |
| SPERMATOGENESIS | 0.102 | Inavolisib | — uncovered |